Hualan Biological Engineering Inc. (002007.SZ)
CNY 17.38
(-0.46%)
CNY 17.38
(-0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.43 Billion | 957.31 Million | 1.43 Billion | 1.32 Billion | 1.36 Billion | 1.29 Billion |
| Net Income | 1.48 Billion | 1.24 Billion | 1.45 Billion | 1.84 Billion | 1.37 Billion | 1.2 Billion |
| Depreciation & Amortization | 273.78 Million | 272.81 Million | 196.44 Million | 181.66 Million | 160.89 Million | 139.27 Million |
| Deferred income taxes | 12.8 Million | -20.82 Million | -9.09 Million | -81.74 Million | 11.15 Thousand | -19.11 Million |
| Stock-based compensation | 35.32 Million | 29.17 Million | 3.03 Million | 18.54 Million | 2.17 Million | - |
| Change in working capital | -576.31 Million | -614.15 Million | -300.79 Million | -704.04 Million | -70.18 Million | 46.33 Million |
| Other non-cash items | 1.4 Billion | 67.05 Million | 88.78 Million | 66.7 Million | -109 Million | -102.51 Million |
| Investing Cash Flow | -1.03 Billion | -2.45 Billion | -1.75 Billion | -739.38 Million | -844.96 Million | -844.29 Million |
| Investments in PPE | -753.41 Million | -393.94 Million | -811.34 Million | -621.44 Million | -272.95 Million | -183.26 Million |
| Acquisitions | 252.18 Million | 2.3 Billion | 909.03 Thousand | 22.34 Thousand | 273.07 Million | -1.27 Million |
| Investment purchases | -6.94 Billion | -12.66 Billion | -14.47 Billion | -11.53 Billion | -8.13 Billion | -6.85 Billion |
| Sales/Maturities of investments | 6.4 Billion | 10.56 Billion | 13.52 Billion | 11.42 Billion | 7.56 Billion | 6.19 Billion |
| Other Investing Activities | -244.86 Million | -2.25 Billion | 0.93 | 109.56 Thousand | -272.95 Million | 133.22 Thousand |
| Financing Cash Flow | -503.02 Million | 1.91 Billion | 35.88 Million | -226.19 Million | -340.76 Million | -221.13 Million |
| Debt repayment | -100 Million | -1 Billion | -700 Million | -50 Million | - | - |
| Dividends payments | -547.31 Million | -364.87 Million | -547.31 Million | -561.34 Million | -390.64 Million | -275.26 Million |
| Common Stock Repurchased | - | 10.56 Million | - | - | - | - |
| Common Stock Issuance | - | -10.56 Million | - | - | 49.88 Million | - |
| Other Financing Activities | -55.33 Million | 3.31 Billion | 1.29 Billion | 395.3 Million | 49.88 Million | 54.12 Million |
| Accounts receivables | -302.65 Million | -538.11 Million | 162.97 Million | -1.24 Billion | -68.07 Million | -199.91 Million |
| Accounts payables | 7.97 Million | 190.01 Million | -137.32 Million | 673.69 Million | 14.35 Million | 229.41 Million |
| Inventory | -316.44 Million | -245.23 Million | -317.35 Million | -48.7 Million | -5.45 Million | 35.95 Million |
| Other working capital | 34.81 Million | -20.82 Million | -9.09 Million | -81.74 Million | -11.01 Million | 10.37 Million |
| Cash at beginning of period | 1.09 Billion | 671.36 Million | 961.81 Million | 602.1 Million | 425.06 Million | 197.86 Million |
| Cash at end of period | 993.76 Million | 1.09 Billion | 671.36 Million | 961.81 Million | 602.1 Million | 425.06 Million |
| Capital Expenditure | -753.41 Million | -393.94 Million | -811.34 Million | -621.44 Million | -272.95 Million | -183.26 Million |
| Effect of forex changes on cash | 63.31 Thousand | 49.75 Thousand | -33.85 Thousand | 4559.45 | -3831.87 | -6537.18 |
| Net cash flow / Change in cash | -104.86 Million | 425.28 Million | -290.44 Million | 359.71 Million | 177.03 Million | 227.2 Million |
| Free Cash Flow | 680.37 Million | 563.36 Million | 621.14 Million | 703.85 Million | 1.08 Billion | 1.1 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 483.46 Million | 178.42 Million | 261.77 Million | 414.29 Million | 1.48 Billion | 540.63 Million |
| Depreciation & Amortization | - | 66.91 Million | 66.91 Million | 69.38 Million | 273.78 Million | -127.44 Million |
| Deferred income taxes | - | - | - | - | 12.8 Million | 662.6 Million |
| Stock-based compensation | - | 22.56 Million | - | 35.32 Million | 35.32 Million | -14.4 Million |
| Change in working capital | - | 189.03 Million | - | -584.28 Million | -576.31 Million | -535.18 Million |
| Other non-cash items | -319.38 Million | 225.33 Million | -161.06 Million | 195.03 Million | 1.4 Billion | -600.96 Million |
| Investing Cash Flow | -1.15 Billion | 1.23 Billion | -114.66 Million | -427.8 Million | -1.03 Billion | -342.28 Million |
| Investments in PPE | -197.03 Million | -150.03 Million | -110.35 Million | -219.45 Million | -753.41 Million | -163.52 Million |
| Acquisitions | 1.54 Million | 256.06 Thousand | 441.2 Thousand | 48.84 Million | 252.18 Million | 184.35 Thousand |
| Investment purchases | -7.14 Billion | -8.34 Billion | -2.07 Billion | -2.42 Billion | -6.94 Billion | -1.26 Billion |
| Sales/Maturities of investments | 6.18 Billion | 9.73 Billion | 2.07 Billion | 2.16 Billion | 6.4 Billion | 1.08 Billion |
| Other Investing Activities | 441.15 Thousand | -200 Thousand | -162.32 Thousand | 1.00 | -244.86 Million | 0.37 |
| Financing Cash Flow | -172.23 Million | -648.9 Million | 193.33 Million | 96.12 Million | -503.02 Million | -3.74 Million |
| Debt repayment | -100 Million | -50 Million | -200 Million | -100 Million | -100 Million | - |
| Dividends payments | -4.19 Million | -459.42 Million | -6.28 Million | -547.31 Million | -547.31 Million | -3.36 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -68.03 Million | -22.46 Million | -6.66 Million | 543.81 Million | -55.33 Million | -380.75 Thousand |
| Accounts receivables | - | 412.48 Million | - | -302.65 Million | -302.65 Million | -883.01 Million |
| Accounts payables | - | - | - | - | 7.97 Million | - |
| Inventory | - | -248.98 Million | - | -316.44 Million | -316.44 Million | 347.82 Million |
| Other working capital | - | 25.54 Million | - | 34.81 Million | 34.81 Million | -14.34 Million |
| Cash at beginning of period | 2.02 Billion | 1.16 Billion | 993.76 Million | 644.2 Million | 1.09 Billion | 1.06 Billion |
| Cash at end of period | 839.73 Million | 2.02 Billion | 1.17 Billion | 993.76 Million | 993.76 Million | 642.22 Million |
| Capital Expenditure | -197.03 Million | -150.03 Million | -110.35 Million | -219.45 Million | -753.41 Million | -163.52 Million |
| Effect of forex changes on cash | 51.19 Thousand | 1902.99 | -99.05 Thousand | 63.4 Thousand | 63.31 Thousand | -18.09 Thousand |
| Net cash flow / Change in cash | -1.18 Billion | 857.15 Million | 176.84 Million | 349.56 Million | -104.86 Million | -420.81 Million |
| Free Cash Flow | -32.95 Million | 186.8 Million | -9.64 Million | 459.25 Million | 680.37 Million | -238.28 Million |
TNHDF
SREA
CHPGF
ALBOO
3899
UNISHIRE